CONMED Corp. (CNMD)
37.91
-1.53
(-3.88%)
USD |
NYSE |
Apr 16, 16:00
37.91
0.00 (0.00%)
After-Hours: 20:00
CONMED Research and Development Expense (Quarterly) : 14.90M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Escalon Medical Corp. | 0.1312M |
| IRIDEX Corp. | 0.949M |
| Electromed, Inc. | 0.384M |
| Guided Therapeutics, Inc. | 0.127M |
| Axogen, Inc. | 12.38M |